Attenuation of oxidative damage and inflammatory responses by apigenin given to mice after irradiation

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 749, Issue 1-2, 2012, Pages 29-38

  Rithidech, Kanokporn Noy ^a   Tungjai, Montree ^a   Reungpatthanaphong, Paiboon ^a,b   Honikel, Louise ^a   Simon, Sanford R ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b KASETSART UNIVERSITY   (Thailand)

Author keywords

Apigenin; Mitigative effects; NF kappa B; Oxidative damage; Post irradiation

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; APIGENIN; CESIUM 137; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD TOXICITY; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA IRRADIATION; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SHAM PROCEDURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APIGENIN; BONE MARROW CELLS; DEOXYGUANOSINE; DNA DAMAGE; GAMMA RAYS; INFLAMMATION; MACROPHAGES; MICE; NF-KAPPA B; OXIDATIVE STRESS;

MUS;

EID: 84869111549     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.08.001     Document Type: Article

References (72)

1. Dent P., Yacoub A., Contessa J., Caron R., Amorino G., Valerie K., Hagan M.P., Grant S., Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat. Res. 2003, 159:283-300.
2. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 2007, 401:1-11.
3. Di Majo V., Coppola M., Rebessi S., Bassani B., Alati T., Saran A., Bangrazi C., Covelli V. Dose-response relationship of radiation-induced harderian gland tumors and myeloid leukemia of the CBA/Cne mouse. J. Natl. Cancer Inst. 1986, 76:955-966.
4. Xu Y., Xin Y., Diao Y., Lu C., Fu J., Luo L., Yin Z. Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS ONE 2011, 6:e29169.
5. Valavanidis A., Vlachogianni T., Fiotakis C. 8-Hydroxy-2'-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health C: Environ. Carcinog. Ecotoxicol. Rev. 2009, 27:120-139.
6. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
7. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
8. Karin M. Nuclear factor-[kappa]B in cancer development and progression. Nature 2006, 441:431-436.
9. Li N., Karin M. Is NF-kappa B the sensor of oxidative stress?. FASEB J. 1999, 13:1137-1143.
10. Wang Y., Meng A., Lang H., Brown S.A., Konopa J.L., Kindy M.S., Schmiedt R.A., Thompson J.S., Zhou D. Activation of nuclear factor {kappa}B in vivo selectively protects the murine small intestine against ionizing radiation-induced damage. Cancer Res. 2004, 64:6240-6246.
11. 56Fe ions. Radiat. Environ. Biophys. 2002, 41:139-144.
12. Karin M., Greten F.R. NF-[kappa]B: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5:749-759.
13. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-[kappa]B functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
14. Dolcet X., Llobet D., Pallares J., Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch. 2005, 446:475-482.
15. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
16. Li Q., Withoff S., Verma I.M. Inflammation-associated cancer: NF-[kappa]B is the lynchpin. Trends Immunol. 2005, 26:318-325.
17. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
18. Miean K.H., Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 2001, 49:3106-3112.
19. F'Guyer S., Afaq F., Mukhtar H. Photochemoprevention of skin cancer by botanical agents. Photodermatol. Photoimmunol. Photomed. 2003, 19:56-72.
20. Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise. Int. J. Oncol. 2007, 30:233-245. (Review).
21. Rithidech K.N., Tungjai M., Whorton E.B. Protective effect of apigenin on radiation-induced chromosomal damage in human lymphocytes. Mutat. Res. 2005, 585:96-104.
22. Begum N., Prasad N.R., Kanimozhi G., Hasan A.Q. Apigenin ameliorates gamma radiation-induced cytogenetic alterations in cultured human blood lymphocytes. Mutat. Res. 2012, 747:71-76.
23. Begum N., Prasad N.R. Apigenin, a dietary antioxidant, modulates gamma radiation-induced oxidative damages in human peripheral blood lymphocytes. Biomed. Prev. Nutr. 2012, 2:16-24.
24. Begum N., Prasad N., Thayalan K. Apigenin protects gamma-radiation induced oxidative stress, hematological changes and animal survival in whole body irradiated Swiss albino mice. J. Nutr. Pharmacol. Neurol. Dis. 2012, 2:45-52.
25. Comalada M., Ballester I., Bailon E., Sierra S., Xaus J., Galvez J., Medina F.S.d., Zarzuelo A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem. Pharmacol. 2006, 72:1010-1021.
26. 137Cs gamma rays. Radiat. Environ. Biophys. 2005, 44:139-143.
27. Kallman R.F., Kohn H.I. The influence of strain on acute X-ray lethality in the mouse. I. LD50 and death rate studies. Radiat. Res. 1956, 5:309-317.
28. Storer J., Acute responses to ionizing radiation Biology of the Laboratory Mouse 1966, The Jackson Laboratory, Bar Harbor, ME. E. Green (Ed.).
29. Taupin P. Apigenin and related compounds stimulate adult neurogenesis. Expert Opin. Ther. Pat. 2009, 19:523-527.
30. Hosoi Y., Miyachi H., Matsumoto Y., Enomoto A., Nakagawa K., Suzuki N., Ono T. Induction of interleukin-1beta and interleukin-6 mRNA by low doses of ionizing radiation in macrophages. Int. J. Cancer 2001, 96:270-276.
31. Rithidech K., Reungpatthanaphong P., Honikel L., Rusek A., Simon S. Dose-rate effects of protons on in vivo activation of nuclear factor-kappa B and cytokines in mouse bone marrow cells. Radiat. Environ. Biophys. 2010, 49:405-419.
32. Zhou D., Yu T., Chen G., Brown S.A., Yu Z., Mattson M.P., Thompson J.S. Effects of NF-κB1 (p50) targeted gene disruption on ionizing radiation-induced NF-κB activation and TNFα, IL-1α, IL-1β and IL-6 mRNA expression in vivo. Int. J. Radiat. Biol. 2001, 77:763-772.
33. Chang C.M., Elliott T.B., Dobson M.E., Jackson W.E., Ledney G.D. Ionizing radiation and bacterial challenge alter splenic cytokine gene expression. J. Radiat. Res. (Tokyo) 2000, 41:259-277.
34. Albanese J., Martens K., Karkanitsa L.V., Dainiak N. Multivariate analysis of low-dose radiation-associated changes in cytokine gene expression profiles using microarray technology. Exp. Hematol. 2007, 35:47-54.
35. Blakely W.F., Ossetrova N.I., Manglapus G.L., Salter C.A., Levine I.H., Jackson W.E., Grace M.B., Prasanna P.G.S., Sandgren D.J., Ledney G.D. Amylase and blood cell-count hematological radiation-injury biomarkers in a rhesus monkey radiation model-use of multiparameter and integrated biological dosimetry. Radiat. Meas. 2007, 42:1164-1170.
36. Ossetrova N.I., Sandgren D.J., Gallego S., Blakely W.F. Combined approach of hematological biomarkers and plasma protein SAA for improvement of radiation dose assessment triage in biodosimetry applications. Health Phys. 2010, 98:204-208.
37. Singh P., Mishra S.K., Noel S., Sharma S., Rath S.K. Acute exposure of apigenin induces hepatotoxicity in Swiss mice. PLoS ONE 2012, 7:e31964.
38. NLM, RTECS (Registry of Toxic Effects of Chemical Substances), National Library of Medicine, Record No. 58596, 1999.
39. Kile B.T., Mason-Garrison C.L., Justice M.J. Sex and strain-related differences in the peripheral blood cell values of inbred mouse strains. Mamm. Genome 2003, 14:81-85.
40. Shukla J., Chatterjee S., Thakur V.S., Premachandran S., Checker R., Poduval T.B. l-Arginine reverses radiation-induced immune dysfunction: the need for optimum treatment window. Radiat. Res. 2009, 171:180-187.
41. Shukla J., Khan N.M., Thakur V.S., Poduval T.B. l-Arginine mitigates radiation-induced early changes in cardiac dysfunction: the role of inflammatory pathways. Radiat. Res. 2011, 176:158-169.
42. Pratheeshkumar P., Raphael T.J., Kuttan G. Protective role of perillic acid against radiation-induced oxidative stress, cytokine profile, DNA damage, and intestinal toxicity in mice. J. Environ. Pathol. Toxicol. Oncol. 2010, 29:1022-1038.
43. Brown S.L., Kolozsvary A., Liu J., Jenrow K.A., Ryu S., Kim J.H. Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality. Radiat. Res. 2010, 173:462-468.
44. Suman S., Maniar M., Fornace A., Datta K. Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response. Radiat. Oncol. 2012, 7:368-376.
45. Li N., Karin M. Ionizing radiation and short wavelength UV activate NF-kappa B through two distinct mechanisms. PNAS 1998, 95:13012-13017.
46. Weichselbaum R.R., Hallahan D., Fuks Z., Kufe D. Radiation induction of immediate early genes: effectors of the radiation-stress response. Int. J. Radiat. Oncol. Biol. Phys. 1994, 30:229-234.
47. Liu Z.-g., Hsu H., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-[kappa]B activation prevents cell death. Cell 1996, 87:565-576.
48. Linard C., Ropenga A., Vozenin-Brotons M.C., Chapel A., Mathe D. Abdominal irradiation increases inflammatory cytokine expression and activates NF-{kappa}B in rat ileal muscularis layer. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G556-G565.
49. Schreiber S., Nikolaus S., Hampe J. Activation of nuclear factor kappaB in inflammatory bowel disease. Gut 1998, 42:477-484.
50. Todorov V.T., Volkl S., Muller M., Bohla A., Klar J., Kunz-Schughart L.A., Hehlgans T., Kurtz A. Tumor necrosis factor-alpha activates NF kappa B to inhibit renin transcription by targeting cAMP-responsive element. J. Biol. Chem. 2004, 279:1458-1467.
51. Catley M.C., Chivers J.E., Cambridge L.M., Holden N., Slater D.M., Staples K.J., Bergmann M.W., Loser P., Barnes P.J., Newton R. IL-1[beta]-dependent activation of NF-[kappa]B mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. FEBS Lett. 2003, 547:75-79.
52. Lancel S., Bachschmid M.M., Kirber M.T., Weinberg E.O. Abstract 3378: IL-33 translocates to the nucleus and has NF-kB transcriptional repressor function following treatment with IL-1beta in human endothelial cells. Circulation 2008, 118. S_415-a-.
53. Barton B.E. IL-6: insights into novel biological activities. Clin. Immunol. Immunopathol. 1997, 85:16-20.
54. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
55. Neta R., Perlstein R., Vogel S.N., Ledney G.D., Abrams J. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J. Exp. Med. 1992, 75:689-694.
56. Czeczot H., Tudek B., Kusztelak J., Szymczyk T., Dobrowolska B., Glinkowska G., Malinowski J., Strzelecka H. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat. Res. 1990, 240:209-216.
57. Gupta S., Afaq F., Mukhtar H. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem. Biophys. Res. Commun. 2001, 287:914-920.
58. NLM ChemIDplus 2000, National Library of Medicine, The National Institutes of Health, Bethesda, MD.
59. Kang S.S., Lee J.Y., Choi Y.K., Kim G.S., Han B.H. Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblastoma cells. Bioorg. Med. Chem. Lett. 2004, 14:2261-2264.
60. Rezai-Zadeh K., Ehrhart J., Bai Y., Sanberg P., Bickford P., Tan J., Shytle R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J. Neuroinflamm. 2008, 5:41.
61. Losi G., Puia G., Garzon G., de Vuono M.C., Baraldi M. Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons. Eur. J. Pharmacol. 2004, 502:41-46.
62. Ha S.K., Lee P., Park J.A., Oh H.R., Lee S.Y., Park J.-H., Lee E.H., Ryu J.H., Lee K.R., Kim S.Y. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem. Int. 2008, 52:878-886.
63. Breinholt V., Hossaini A., Svendsen G.W., Brouwer C., Nielsen S.E. Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem. Toxicol. 2000, 38:555-564.
64. Miksicek R.J. Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 1993, 44:37-43.
65. Lepley D.M., Li B., Birt D.F., Pelling J.C. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 1996, 17:2367-2375.
66. McVean M., Weinberg W.C., Pelling J.C. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin. Mol. Carcinogen. 2002, 33:36-43.
67. Snyder R.D., Gillies P.J. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen. 2002, 40:266-276.
68. Webb M.R., Ebeler S.E. Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity. Biochem. J. 2004, 384:527-541.
69. Strick R., Strissel P.L., Borgers S., Smith S.L., Rowley J.D. From the cover: dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. PNAS 2000, 97:4790-4795.
70. Ross J.A. Dietary flavonoids and the MLL gene: a pathway to infant leukemia?. PNAS 2000, 97:4411-4413.
71. Nielsen S., Young J., Daneshvar B., Lauridsen S., Knuthsen P., Sandstrom B., Dragsted L. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br. J. Nutr. 1999, 81:447-455.
72. Gradolatto A., Basly J., Berges R., Teyssier C., Chagnon M., Siess M., Canivenc-Lavier M. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab. Dispos. 2005, 33:49-54.